The effect of esculentoside A on lupus nephritis-prone BXSB mice

Archives of Medical Science

Volumn 9, Issue 2, 2013, Pages 354-360

  Ma, Hualin ^a   Zhang, Xianggui ^b   Zhang, Xinzhou ^a   Yang, Dan ^b   Meng, Lingguo ^b   Zhang, Yi ^c   Zhou, Shuyan ^c  

^a JINAN UNIVERSITY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF JINAN   (China)

Author keywords

Apoptosis; BXSB mice; Cytokine; Esculentoside A; Proliferation

Indexed keywords

ANTIINFLAMMATORY AGENT; CASPASE 3; DEXAMETHASONE; ESCULENTOSIDE A; FAS LIGAND; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NICK END LABELING; NONHUMAN; URINALYSIS; UROGENITAL SYSTEM PARAMETERS;

EID: 84876897959     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.31439     Document Type: Article

References (30)

1. Avihingsanon Y, Hirankarn N. Major lupus organ involvement: severe lupus nephritis. Lupus 2010; 19: 1391-8.
2. Ding ZX, Yang SF, Wu QF, et al. Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mic. Nan Fang Yi Ke Da Xue Xue Bao 2011; 31: 656-60.
3. Wu X, Zhang W, Shi X, An P, Sun W, Wang Z. Therapeutic effect of artemisinin on lupus nephritis mice and its mechanisms. Acta Biochim Biophys Sin 2010; 42: 916-23.
4. Xiao ZY, Zheng QY, Zhang JP, Jiang YY, Yi YH. Effect of esculentoside A on autoimmunity in mice and its possible mechanisms. Acta Pharmacol Sin 2002; 23: 638-44.
5. Xiao ZY, Zheng QY, Jiang YY, et al. Effects of esculentoside A on production of interleukin-1, 2, and prostaglandin E2. Acta Pharmacol Sin 2004; 25: 817-21.
6. Xiong N, Zhang Z, Huang J, et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Therapy 2010; 18: 394-402.
7. Hu Z, Qiu L, Xiao Z, et al. Effects of esculentoside A on autoimmune syndrome induced by Campylobacterjejuni in mice and its modulation on T-lymphocyte proliferation and apoptosis. Int Immunopharmacol 2010; 10: 65-71.
8. Hogarth MB, Slingsby JH, Allen PJ, et al. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J Immu nol 1998; 161: 2753-61. (Pubitemid 28425694)
9. Haywood ME, Rogers NJ, Rose SJ, et al. Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease. J Immunol 2004; 173: 4277-85. (Pubitemid 39280655)
10. Cheung YH, Loh C, Pau E, Kim J, Wither J. Insights into the genetic basis and immunopathogenesis of systemic lupus erythematosus from the study of mouse models. Semin Immunol 2009; 21: 372-82.
11. Mok CC. Biomarkers for lupus nephritis: a critical appraisal. J Biomed Biotechnol 2010; 2010: 638413.
12. Li Z, Tong H, Zhang Y, et al. An experimental study on the effect of Leflunomide in BXSB lupus mice. Chin J Dermatol 2004; 37: 662-5.
13. Avrǎmescu C, Biciuşcǎ V, Dǎianu T, et al. Cytokine panel and histopathological aspects in the systemic lupus erythematosus. Rom J Morphol Embryol 2010; 51: 633-40.
14. Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 1988; 331: 356-8. (Pubitemid 18042493)
15. Boswell JM, Yui MA, Burt DW, Kelley VE. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988; 141: 3050-4.
16. Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 2000; 6: 441-8.
17. Coleman DL, Ruef C. Interleukin-6: an autocrine regulator of mesangial cell growth. Kidney Int 1992; 41: 604-6.
18. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516. (Pubitemid 46911891)
19. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 2006; 239: 121-8. (Pubitemid 44037544)
20. Singh R, Pradhan V, Patwardhan M, Ghosh K. APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases. Indian J Hum Genet 2009; 15: 98-102.
21. Fathi NA, Hussein MR, Hassan HI, Mosad E, Galal H, Afifi NA. Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings. Clin Exp Immunol 2006; 146: 339-43. (Pubitemid 44581350)
22. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest 2005; 115: 2665-72. (Pubitemid 41434390)
23. Bonomini M, Dottori S, Amoroso L, Arduini A, Sirolli V. Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia. J Thromb Haemost 2004; 2: 1275-81. (Pubitemid 40186122)
24. Li X, Huang JP, Ding J. Apoptosis and expressions of PDCD5 and Caspase-3 in renal tissues of children with lupus nephritis. Zhonghua Er Ke Za Zhi 2005; 43: 517-20.
25. Jani A, Ljubanovic D, Faubel S, Kim J, Mischak R, Edelstein CL. Caspase inhibition prevents the increase in caspase-3, -2, -8 and -9 activity and apoptosis in the cold ischemic mouse kidney. Am J Transplant 2004; 4: 1246-54. (Pubitemid 39013570)
26. Yang B, El Nahas AM, Thomas GL, et al. Caspase-3 and apoptosis in experimental chronic renal scarring. Kidney Int 2001; 60: 1765-76. (Pubitemid 32999981)
27. Kochaniak AB, Habuchi S, Loparo JJ, et al. Proliferating cell nuclear antigen uses two distinct modes to move along DNA. J Biol Chem 2009; 284: 17700-10.
28. Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot 2011; 107: 1127-40.
29. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994; 94: 2105-16. (Pubitemid 24348252)
30. Lee DW, Kwak IS, Lee SB, et al. Post-treatment effects of erythropoietin and nordihydroguaiaretic acid on recovery from cisplatin-induced acute renal failure in the rat. J Korean Med Sci 2009; 24 Suppl: S170-5.